Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

JPM Health Conference Days 1-2: What You Need To Know No Photo Available

Yeji Jesse Lee

The J.P. Morgan Healthcare Conference kicked off in San Francisco, with surprisingly good weather and a handful of blockbuster announc... (more story)

HHS' Strategic Plan For Healthcare AI: 3 Things To Know No Photo Available

Dan McKay

A federal strategic plan for the use of artificial intelligence in healthcare calls for setting clear regulations and collaborating wi... (more story)

How Calif. Became 1st State To Ban AI Healthcare Denials No Photo Available

Hannah Albarazi

Amid growing concerns about healthcare insurance claims and artificial intelligence, a first-of-its-kind California law requires a qua... (more story)